Lotus Pharmaceuticals, Inc. (LTUS)

Market Cap	21.24M
Revenue (ttm)	71.39M
Net Income (ttm)	1.72M
Shares Out	2.64B
EPS (ttm)	0.06
PE Ratio	0.13
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	862
Average Volume	46,716
Open	0.0083
Previous Close	0.0054
Day's Range	0.0083 - 0.0083
52-Week Range	0.0006 - 0.0111
Beta	-2.55
RSI	50.61
Earnings Date	n/a

About Paramount Global

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People’s Republic of China. The company is based in Nashville, Tennessee.

• Industry: Shell Companies
• Sector: Financials
• CEO: Zhong Yi Liu
• Employees: 383
• Stock Exchange: OTCMKTS
• Ticker Symbol: LTUS

Financial Performance

In 2010, Lotus Pharmaceuticals's revenue was $72.70 million, an increase of 28.71% compared to the previous year's $56.48 million. Earnings were $14.42 million, a decrease of -12.22%.